AGP Executive Report
Last update: an hour agoFederal Hemp Rules: Congress delayed the new total-THC limits and per-container cap until Dec. 11, but a ban on synthetic cannabinoids still starts Nov. 12. The changes could push many hemp-derived CBD and THC products off shelves. Prescription CBD: Kazmira Therapeutics partnered with CareValidate to offer prescription-only, THC-free compounded CBD through telehealth, positioning the model for tighter rules. Global Expansion: MediPharm Labs shipped its first CBD metered-dose inhaler to Panama, extending its medical cannabis reach.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.